- Home
- IRMD vs SANA Comparison
IRMD vs SANA Comparison
Compare IRMD & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRMD | SANA |
|---|---|---|
| Founded | 1992 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IRMD | SANA |
|---|---|---|
| Price | $99.25 | $4.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $72.00 | $7.83 |
| AVG Volume (30 Days) | 89.1K | ★ 3.9M |
| Earning Date | 02-12-2026 | 11-06-2025 |
| Dividend Yield | ★ 0.69% | N/A |
| EPS Growth | ★ 13.00 | N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $80,511,268.00 | N/A |
| Revenue This Year | $15.17 | N/A |
| Revenue Next Year | $10.15 | N/A |
| P/E Ratio | $59.98 | ★ N/A |
| Revenue Growth | ★ 12.91 | N/A |
| 52 Week Low | $47.48 | $1.26 |
| 52 Week High | $100.39 | $6.55 |
Technical Indicators
Market Signals| Indicator | IRMD | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 62.48 | 53.24 |
| Support Level | $97.39 | $4.01 |
| Resistance Level | $100.01 | $4.91 |
| Average True Range (ATR) | 2.31 | 0.27 |
| MACD | -0.23 | 0.01 |
| Stochastic Oscillator | 83.45 | 65.31 |
Price Performance
Historical ComparisonAbout IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.